Solganick & Co.

JANUARY 15, 2025

Valuation multiples for publicly-traded cybersecurity companies ranged from a median of 14.3x Cybersecurity M&A Deal Volume, Q1 2022 – Q4 2024 The report covers recent M&A transactions announced, an industry landscape, public comparables, and a valuation table for the cybersecurity industry.

Mergers and Acquisitions 40

Mergers and Acquisitions M&A Mergers Acquisitions 40

Focus Investment Banking

JANUARY 18, 2024

The S&P 500 has recently traded near 4800, close to its record at the end of 2021. It has taken two years to return to those levels, after 2022 and 2023 were burdened with interest rate hikes and fears of a recession. There are only a few publicly traded companies in specialty consulting. As 2024 starts, the U.S.

IPO 52

IPO Consulting Corporate Finance Professional Services 52

Solganick & Co.

OCTOBER 15, 2024

It covers the latest mergers and acquisitions deal announcements, valuations, public company data, and other trends announced in Q3 2024. Valuation multiples for publicly-traded cybersecurity companies ranged from a median 9.5x EV/2024E revenue for high growth (>20%) vendors to a median 4.0x

Mergers and Acquisitions 40

Mergers and Acquisitions Mergers Acquisitions M&A 40

Cooley M&A

JANUARY 19, 2023

The Inflation Reduction Act imposes a 1% excise tax on certain repurchases of stock of publicly traded US corporations (“Covered Corporations”) effected after December 31, 2022 (the “Excise Tax”). [1] because SPAC sponsor shares are forfeited and not entitled to receive any distributions upon liquidation).

M&A 52

M&A Capital Market Stock Mergers and Acquisitions 52

Viking Mergers & Acquisitions

APRIL 17, 2023

He worked with large publicly traded engineering and technology companies, small privately owned businesses, and several government entities. He joined Viking Mergers & Acquisitions in 2022 to serve the entire Myrtle Beach, Grand Strand area of South Carolina as well as the Wilmington, North Carolina, market.

Mergers and Acquisitions 52

Mergers and Acquisitions M&A Business Broker 52

Wall Street Mojo

FEBRUARY 9, 2024

When listed as publicly traded companies, they mostly become small-cap and micro-cap stocks trading on the exchange. Since the company is new, it is less in valuation, but Ryan is adamant about offering better products and services. In 2022, the company generated an annual revenue of $9 million.

Middle Market 52

Middle Market Bulge Bracket Private Equity Investment Banking 52

Software Equity Group

APRIL 4, 2023

Our panel comprises leaders well-versed in go-to-market operations for SaaS businesses of all types, from bootstrapped startups to PE-backed and publicly traded companies. According to MarTech.org, there were over 9,932 MarTech tools and platforms available as of 2022.

Sale 52

Sale Book-building Business M&A 52

Cooley M&A

JANUARY 25, 2023

Tech M&A in 2022 was a tale of two halves. billion [1] during the first half of 2022 to $189.17 billion in the second half, resulting in total 2022 volume of $720.3 billion [1] during the first half of 2022 to $189.17 billion in the second half, resulting in total 2022 volume of $720.3 trillion. [2] trillion.

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Cooley M&A

JANUARY 20, 2022

While 2020’s M&A landscape was characterized by whiplash volatility from choppy deal activity in the first half of the year to a surge in volume in the second half, that momentum accelerated in 2021, with no signs of slowing down heading into 2022. billion , Acceleron Pharma’s agreement to sell to Merck for $11.5

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Focus Investment Banking

DECEMBER 20, 2024

While Retina groups were already receiving competitive valuations from private equity-backed companies like EyeSouth Partners and NVision Eye Centers, the RCA-Cencora transaction indicates there are long-term buyers outside of private equity for retina practices with the capital to acquire and operate them.

Private Equity 52

Private Equity Healthcare Equities Sale 52

Cooley M&A

JANUARY 22, 2025

This stands in stark contrast to 2023, when life sciences M&A outperformed the market with a 50% increase in deal value from 2022 compared to a 17% decline in overall M&A activity across all industries. Luckily, theres more to this years story.

M&A 64

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 64